GlassScriptPhysician profile
Gregg M Ebersole
NPI 1093000366
$7,296.75
in general payments reported to CMS, 2019-2025
26 companies · $1,463 in 2025
The $1,463 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $455 · 2021: $1,023 · 2022: $1,191 · 2023: $746 · 2024: $1,200 · 2025: $1,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,208 · Education: $185 · Travel and Lodging: $14.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,208.03 |
| Education | $185.12 |
| Travel and Lodging | $14.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,711.49 | 2019-2025 | Gamma, T2, Mako |
| Smith+Nephew, INC. | $955.49 | 2019-2025 | Redapt, Tandem, Journey II |
| Zimmer Biomet Holdings, INC. | $546.80 | 2019-2025 | Persona, Rosa, Orthogrid Hip |
| Depuy Synthes Sales INC. | $316.32 | 2019-2023 | Dynatape |
| Linkbio Corp | $206.66 | 2024 | |
| Medacta USA, INC. | $192.10 | 2024 | |
| Ortho Development Corporation | $190.76 | 2019-2020 | |
| Amgen INC. | $172.86 | 2019-2025 | Evenity, Prolia |
| Pacira Therapeutics, INC. | $165.20 | 2019-2020 | |
| Integra Lifesciences Corporation | $148.36 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Vertex Pharmaceuticals Incorporated | $122.22 | 2025 | |
| Orthofix Medical, INC. | $109.64 | 2022-2025 | Physio-Stim |
| Radius Health, INC. | $91.03 | 2021-2023 | Tymlos |
| Mallinckrodt Enterprises LLC | $57.01 | 2019 | |
| Kerecis Limited | $53.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $40.34 | 2022 | |
| Bioventus LLC | $35.95 | 2020-2025 | Durolane |
| Lilly USA, LLC | $30.82 | 2022-2023 | Taltz, Olumiant |
| Kci USA, INC. | $25.90 | 2020-2023 | Prevena Restor Axioform, Prevena Restor Arthroform |
| Organogenesis INC. | $23.87 | 2021 | |
| Haemonetics Corporation | $23.60 | 2019 | |
| Dusa Pharmaceuticals, INC. | $20.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.27 | 2021 | |
| Merz North America, INC. | $14.13 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2019 | |
| Sanofi Pasteur INC. | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Ebersole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.